Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights GlobeNewswire August 01, 2025 Updated cash guidance provides runway into at least the middle of calendar 2026 Company remains encouraged by MDNA11 clinical results presented to-date, demonstrating best-in-class potential of our IL-2 superkine by exceeding ORR benchmarks demonstrated with other competing therapies in […]